Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary K Oates

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 15, 2012
Visceral adipose tissue quantification using Lunar ProdigyDavid L Ergun, Megan P Rothney, Mary K Oates, et al.
JBMR Plus|July 14, 2021
Skeletal responses to romosozumab after 12 months of denosumabMichael R McClung, Michael A Bolognese, Jacques P Brown, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 15, 2022
Romosozumab and antiresorptive treatment: the importance of treatment sequenceFelicia Cosman, David L Kendler, Bente L Langdahl, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2021
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trialJacques P Brown, Klaus Engelke, Tony M Keaveny, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 15, 2012
Visceral adipose tissue quantification using Lunar ProdigyDavid L Ergun, Megan P Rothney, Mary K Oates, et al.
JBMR Plus|July 14, 2021
Skeletal responses to romosozumab after 12 months of denosumabMichael R McClung, Michael A Bolognese, Jacques P Brown, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 15, 2022
Romosozumab and antiresorptive treatment: the importance of treatment sequenceFelicia Cosman, David L Kendler, Bente L Langdahl, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2021
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trialJacques P Brown, Klaus Engelke, Tony M Keaveny, et al.
Pageof 1